Patent · US Active

Process for the manufacturing of sevoflurane

US8729313B2 · kind B2 · utility

1Cited by
16References
34Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 15, 2011
Grant dateMay 20, 2014
Priority date
Expiry dateNov 12, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C43/123
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides a method for forming sevoflurane comprising (i) combining chlorosevo ether, a nucleophilic fluoride reagent, and a solvent comprising sevoflurane to form an initial reaction mixture and (ii) reacting the initial reaction mixture to form additional sevoflurane relative to the amount of sevoflurane present in the initial reaction mixture. The present disclosure is also directed to a method for forming sevoflurane, comprising: initiating a reaction between chlorosevo ether and a nucleophilic fluoride reagent in an initial reaction mixture further comprising a solvent comprising sevoflurane, thereby forming additional sevoflurane relative to the amount of sevoflurane present in the initial reaction mixture.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.